Sepsis after bipolar radiofrequency endometrial ablation

Obstetrics and Gynecology

Volumn 114, Issue 2 PART 2 SUPPL., 2009, Pages 445-448

  Salmeen, Kirsten ^a,b   Morgan, Daniel ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CEFAZOLIN; CLINDAMYCIN; ERTAPENEM; GENTAMICIN; VANCOMYCIN;

ADD ON THERAPY; ANTIBIOTIC THERAPY; ARTICLE; BLOOD CULTURE; BLOOD PRESSURE REGULATION; CASE REPORT; CHILL; CLIMACTERIUM; DIARRHEA; DISEASE EXACERBATION; EMERGENCY CARE; ENDOMETRIUM ABLATION; ESCHERICHIA COLI; FEMALE; FEVER; FLUID RESUSCITATION; HUMAN; HYPOTENSION; HYSTERECTOMY; INFLAMMATION; INTENSIVE CARE; INTRAVENOUS ADMINISTRATION; LAPAROTOMY; LEUKOCYTE COUNT; MALAISE; MENORRHAGIA; MYOMETRIUM; POSTOPERATIVE INFECTION; PRIORITY JOURNAL; RADIOFREQUENCY ABLATION; SALPINGITIS; SEPSIS; THERMAL INJURY; THROMBOCYTE COUNT; TISSUE CULTURE; TREATMENT RESPONSE; UTERINE CERVICITIS; VOMITING;

ENDOMETRIAL ABLATION TECHNIQUES; ESCHERICHIA COLI INFECTIONS; FEMALE; HUMANS; HYSTERECTOMY; MENORRHAGIA; PERIMENOPAUSE; SEPSIS;

EID: 68949093685     PISSN: 00297844     EISSN: None     Source Type: Journal    
DOI: 10.1097/AOG.0b013e3181a6e05c     Document Type: Article

References (8)

1. Cooper J, Gimpelson RJ. Summary of safety and effectiveness data from FDA, a valuable source of information on the performance of global endometrial ablation devices. J Reprod Med 2004;49:267-73.
2. US Food and Drug Administration. Summary of safety and effectiveness data: NovaSure™ Impedance Controlled Endometrial Ablation System. Available at: http://www.fda.gov/cdrh/pdf/P010013b.pdf. Retrieved April 5, 2008.
3. Roy KH, Mattox JH. Advances in endometrial ablation. Obstet Gynecol Surv 2002;57:789-802.
4. Cooper J, Gimpelson R, Laberge P, Galen D, Garza-Leal JG, Scott J, et al. A randomized, multicenter trial of safety and efficacy of the NovaSure system in the treatment of menorrhagia. J Am Assoc Gynecol Laparosc 2002;9:418-28.
5. Gallinat A. NovaSure impedance controlled system for endometrial ablation: three-year follow-up on 107 patients. Am J Obstet Gynecol 2004;191:1585-9.
6. Busund B, Erno LE, Gronmark A, Istre O. Endometrial ablation with NovaSure GEA, a pilot study. Acta Obstet Gynecol Scand 2003;82:65-8.
7. Gurtcheff SE, Sharp HT. Complications associated with global endometrial ablation: the utility of the MAUDE database. Obstet Gynecol 2003;102:1278-82.
8. Thinkhamrop J, Laopaiboon M, Lumbiganon P. Prophylactic antibiotics for transcervical intrauterine procedures. The Cochrane Database of Systematic Reviews 2007, Issue 3. Art. No.: CD005637. DOI: 10.1002/14651858.CD005637.pub2.